MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹925 Cr | ₹1,019 Cr | ₹89 Cr | ₹48 Cr | ₹83 Cr |
What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹925 Cr |
| Mar2025 | ₹1,019 Cr |
| Mar2024 | ₹89 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹83 Cr |
How is Contingent Liabilities of MANKIND PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹925 Cr | -9.29 | |
| Mar2025 | ₹1,019 Cr | 1,045.33 | |
| Mar2024 | ₹89 Cr | 85.77 | |
| Mar2023 | ₹48 Cr | -41.97 | |
| Mar2022 | ₹83 Cr | - | |
Compare Contingent Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹100,352.8 Cr | 6.2% | 1.9% | -10.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 6.2% |
1.9% |
-10.3% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses